Spotlighting undiscovered companies with enormous upside potential.
Contact us:
(310) 299-1717
Spotlighting undiscovered companies with enormous upside potential.
Home
About
Tiny Gems
NewsRoom
Newsletter Archives
Events
Contact
Headlines
GEMXX Corp. (GEMZ) Announces Definitive Agreement with Latin Energy Partners in Strategic Latin America Venture
Mullen Automotive Inc. (MULN) Subsidiary Announces First Dealership Deal in Market Projected to See Record Sales
InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy
Lexaria Bioscience Corp. (LEXX) Yields “Extremely Interesting” Results for DehydraTECH(TM) Liraglutide
Clene Inc. (CLNN) Presents Promising Preliminary Data on CNM-Au8(R) for Rett Syndrome Treatment
Home
/
NewsRoom
TinyGemsBreaks
Headline
Company of Focus
Date
TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Market Potential with Unique Delivery Platform, GLP-1 Program
Lexaria Bioscience Corp. (LEXX)
September 13, 2024
TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) to Effect 1-for-100 Reverse Stock Split
Mullen Automotive Inc. (MULN)
September 13, 2024
TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary Gains ‘Strong Foothold’ in California’s Central Valley on Newly Named Dealer
Mullen Automotive Inc. (MULN)
September 11, 2024
TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary Achieves ‘Important Accomplishment’ with CARB Certification
Mullen Automotive Inc. (MULN)
September 9, 2024
TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Shares Letter from Outgoing CEO
Lexaria Bioscience Corp. (LEXX)
September 6, 2024
View All TinyGemsBreaks
TinyGems Articles
Headline
Company of Focus
Date
Lexaria Bioscience Corp. (NASDAQ: LEXX) Yields “Extremely Interesting” Results for DehydraTECH(TM) Liraglutide in Ongoing Diabetes Animal Study
Lexaria Bioscience Corp. (LEXX)
September 5, 2024
InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy
InMed Pharmaceuticals Inc. (INM)
August 29, 2024
Lexaria Bioscience Corp. (NASDAQ: LEXX) Validates Technology’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market
Lexaria Bioscience Corp. (LEXX)
August 26, 2024
InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer’s Drug INM-901
InMed Pharmaceuticals Inc. (INM)
August 26, 2024
Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Oral GLP-1 Alternatives for Diabetes and Obesity Treatment
Lexaria Bioscience Corp. (LEXX)
August 16, 2024
View All Articles
Public Press Releases
Filter Releases
Sectors
Aerospace and Defense
Banking and Finance
Banking
Biotechnology
Internet
Media
Metal and Mineral
Chemicals
Computer
Consumer Goods
Pharmaceutical
Oil & Energy
Real Estate
Software
Energy
Entertainment
Food and Beverage
Healthcare
Telecommunications
Transportation
Utilities
Remove All Filters
Symbol
Release
Time
Source
{{ release.qmtopics.qmsymbol[0].symbol }}
{{ release.headline }}
{{ release.datetime | amDateFormat:'hh:mm A'}}
{{ release.source }}
Load More Articles
Contact us:
(310) 299-1717